Join
Live feed
·
INSIDERFilingvia Quantisnow
Revelation Biosciences Inc. logo

Chief Executive Officer Rolke James was granted 30,095 shares, increasing direct ownership by 71,655% to 30,137 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
REVB· Revelation Biosciences Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track REVB (Revelation Biosciences Inc.) and more on Quantisnow.